Casa Sollievo della Sofferenza

Recent papers from Casa Sollievo della Sofferenza

1. Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter‐Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint InterpretationEuropean Journal Of Haematology · 2026
2. Qualitative insights from partners of individuals with Huntington’s disease: the quality of life of an under-researched populationOrphanet Journal of Rare Diseases · 2026
3. Genomic, clinical, and radiological characterization of spontaneous cervical artery dissections: Findings from a single-center cohortJournal of the Neurological Sciences · 2026
4. Rotavirus Vaccine Effectiveness Against Hospitalization for Rotavirus Gastroenteritis in Children Under 5 years: A Test-Negative Study in Southern Italy, 2018–2025Infectious Diseases and Therapy · 2026
5. The impact of PROgnostic SIgnatures in stage II colon cancer patients enrolled in the phase III clinical trial TOSCA: the PROSIT study.2026
6. Acute Myocarditis: Contemporary Diagnosis, Risk Stratification and Management, with a Focus on Heart Failure and Fulminant PresentationsJournal of Cardiovascular Development and Disease · 2026
7. Twelve novel Italian cases of hypophosphatasia: challenging cases with an extremely variable phenotypeFrontiers in Endocrinology · 2026
8. Clinical and Genetic Characterization of Preschool Girls with Autism Spectrum Disorder: Insights from Copy Number Variants and X-Chromosome InactivationChildren · 2026
9. Autosomal dominant polycystic kidney disease in ItalyNephrology Dialysis Transplantation · 2026
10. Exploring the relationship between cancer type and non-cancer pain management (ARISE-1 study)Scientific Reports · 2026
11. Pharmacotherapeutic management of chronic pain in joint hypermobility and Ehlers-Danlos syndromes: a clinical perspectiveExpert Opinion on Pharmacotherapy · 2026
12. All-cause mortality in people with type 2 diabetes and lipodystrophy-like metabolic phenotypeJournal of the Endocrine Society · 2026
13. Empagliflozin in Lafora disease: A first‐in‐human 6‐month pilot study with electroclinical and FDG‐PET findingsEpileptic Disorders · 2026
14. Beyond seizure control: Non–seizure‐related outcomes in focal‐onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS studyEpilepsia · 2026
15. Two pediatric type II achalasia cases complicated by candidal and eosinophilic esophagitis: Successful peroral endoscopic myotomy treatmentJPGN Reports · 2026
16. Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registryMultiple Sclerosis Journal · 2026
17. Facial palsy after cochlear implantation: incidence, etiology, and treatment outcomes: a systematic review and meta-analysisCochlear Implants International · 2026
18. Connecting the dots in cardiovascular medicine: endometriosis, chronic inflammation, and venous thromboembolismEuropean Heart Journal · 2026
19. Ki-67 antigen in lung carcinoids/neuroendocrine tumors: from a proliferation marker to a clinical compassExpert Review of Respiratory Medicine · 2026
20. Prostatic urethral lift in young men seeking preservation of ejaculatory function and fertility-related parameters: semen analysis up to 18 months and comparative review of MISTMinerva Urology and Nephrology · 2026